Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schizophrenia: One Name, Many Different Manifestations
Justin Faden, Leslie Citrome
Medical Clinics of North America (2022) Vol. 107, Iss. 1, pp. 61-72
Closed Access | Times Cited: 39

Showing 26-50 of 39 citing articles:

Attitude towards mental help-seeking, motivation, and economic resources in connection with positive, negative, and general psychopathological symptoms of schizophrenia: a pilot study of a psychoeducation program
Qasir Abbas, Khawar Bilal Baig, Urooj Sadiq, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Pregnancy as a challenge for a patient with schizophrenia
Julia Bogucka, Anna Brzyska, Małgorzata Bojarska, et al.
Current Problems of Psychiatry (2024) Vol. 25, pp. 156-164
Open Access
Psychotropic medication and hepatobiliary health: Ultrasound observations on patients with schizophrenia
Linlin Yue, Linlin Sun, Nan Li
The International Journal of Psychiatry in Medicine (2024)
Closed Access
Possible Mechanism for Perception of Auditory-Verbal Hallucinations in Schizophrenia and Approaches to Their Weakening
И. Г. Силькис
Neurochemical Journal (2024) Vol. 18, Iss. 3, pp. 434-447
Closed Access
Altered intrinsic neural activity and its molecular analyses in first-episode schizophrenia with auditory verbal hallucinations
Ziyu Wang, Kangkang Xue, Yimeng Kang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access
Exploring the Therapeutic Mechanism of Pingxin Dingzhi Decoction Through Network Pharmacology and Molecular Docking
Xiaojie Ju, Chunhua Qi, Yulong Bai, et al.
ALPHA PSYCHIATRY (2024) Vol. 25, Iss. 5, pp. 584-591
Closed Access
Hyperbaric Oxygen Therapy Ameliorates Olanzapine-Induced Hypolocomotion in a Rat Model
Ahmad Altarifi, Lobna R. Ezz El Arab, Rasha Al-Azaizeh, et al.
Life (2024) Vol. 14, Iss. 11, pp. 1482-1482
Open Access
Transcranial Direct Current Stimulation (tDCS) Enhances Cognitive Function in Schizophrenia: A Randomized Double-Blind Sham-Controlled Trial
Lorena García‐Fernández, Verónica Romero‐Ferreiro, Sergio Padilla, et al.
Psychiatry Research (2024) Vol. 344, pp. 116308-116308
Open Access
Association between elevated serum matrix metalloproteinase-2 and tumor necrosis factor-α, and clinical symptoms in male patients with treatment-resistant and chronic medicated schizophrenia
Haidong Yang, Ruijie Peng, Man Yang, et al.
Research Square (Research Square) (2024)
Open Access
Decreased serum VEGF and NRG1β1 levels in male patients with chronic schizophrenia: VEGF correlation with clinical symptoms and cognitive deficits
Peng Chen, Wanming Chen, Li Xu, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 85-92
Closed Access
A real-world data analysis of electronic health records to investigate the associations of predominant negative symptoms with healthcare resource utilisation, costs and treatment patterns among patients with schizophrenia
Rashmi Patel, Carole Dembek, Yida Won, et al.
BMJ Open (2024) Vol. 14, Iss. 7, pp. e084613-e084613
Open Access
Discovering functional interactions among schizophrenia-risk genes by combining behavioral genetics with cell biology
Di Ma, Chen Gu
Neuroscience & Biobehavioral Reviews (2024), pp. 105897-105897
Closed Access
Possible Mechanism for Perception of Auditory-Verbal Hallucinations in Schizophrenia and Approaches to Their Weakening
I. G. Silkis
Нейрохимия (2024) Vol. 41, Iss. 2, pp. 124-139
Closed Access
The efficacy and safety of dual-target rTMS over dorsolateral prefrontal cortex (DLPFC) and cerebellum in the treatment of negative symptoms in first-episode schizophrenia: Protocol for a multicenter, randomized, double-blind, sham-controlled study
Jijun Wang, YanYan Wei, Qiang Hu, et al.
Schizophrenia Research Cognition (2024) Vol. 39, pp. 100339-100339
Closed Access
Vive la révolution! a paradigm shift in the pharmacological treatment of schizophrenia
Leslie Citrome
Current Medical Research and Opinion (2023) Vol. 39, Iss. 3, pp. 473-474
Closed Access | Times Cited: 1
A multicenter, double‐blind, randomized, controlled study of patients with treatment‐resistant schizophrenia treated with yokukansan for 12 weeks
Jun Horiguchi, Rei Wake, Kenta Murotani, et al.
Psychiatry and Clinical Neurosciences Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 1
Immediate and Delayed Effects of Environmental Temperature on Schizophrenia Admissions in Liuzhou, China, 2013–2020: A Time-Series Analysis
Qian Zhou, Xiaolan Huang, Li Su, et al.
Research Square (Research Square) (2023)
Open Access
Major Psychiatric Disorders
Wolfgang Walz
Springer eBooks (2023), pp. 207-230
Closed Access
Valoración funcional mediante estimulación magnética transcraneal de la transmisión inhibitoria en esquizofrenia.
Inés Fernández Linsenbarth
(2023)
Open Access
Previous Page - Page 2

Scroll to top